Dr. Herta H. Chao
Claim this profileVeterans Affairs Connecticut Healthcare System-West Haven Campus
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
29 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Herta H. Chao is currently running
High Dose Testosterone
for Prostate Cancer
This study will determine whether the presence of DNA repair deficiency in the form of alterations in the genes ATM, CDK12 or CHEK2 predicts for a high likelihood of responding to the use of intermittent high dose testosterone. This therapy may result in responses in tumors which are genetically unstable because of DNA repair deficiency and this is a prospective study to test that hypothesis
Recruiting3 awards Phase 2
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Herta H. Chao
Clinical Trial Related4 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Herta H. Chao has experience with
- Pembrolizumab
- Biospecimen Collection
- Carboplatin
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
- Nivolumab
Breakdown of trials Herta H. Chao has run
Lung Cancer
Non-Small Cell Lung Cancer
Lung Carcinoma
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Herta H. Chao specialize in?
Herta H. Chao focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Herta H. Chao currently recruiting for clinical trials?
Yes, Herta H. Chao is currently recruiting for 5 clinical trials in West Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Herta H. Chao has studied deeply?
Yes, Herta H. Chao has studied treatments such as Pembrolizumab, Biospecimen Collection, Carboplatin.
What is the best way to schedule an appointment with Herta H. Chao?
Apply for one of the trials that Herta H. Chao is conducting.
What is the office address of Herta H. Chao?
The office of Herta H. Chao is located at: Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven, Connecticut 06516 United States. This is the address for their practice at the Veterans Affairs Connecticut Healthcare System-West Haven Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.